Kusajili – Clinical trials directory

Result of your search per sponsor: Philippe GRISE, MD

Woman and Man Max 99 years
Philippe GRISE, MD Update Il y a 4 ans

NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder The purpose of this study is to determine the efficacy and tolerance of 2 dosages (750 versus 500 units) of the Dysport type A botulinic toxin for patient suffering from neurogenic urinary...

Country France
organs None
Specialty None

Closed trial

More information